![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » CELERA, MEDAREX COLLABORATE ON THERAPEUTIC ANTIBODY
CELERA, MEDAREX COLLABORATE ON THERAPEUTIC ANTIBODY
June 26, 2006
Celera Genomics, an Applera Corporation business, and Medarex Inc. have entered into a collaboration to discover and develop human antibodies for the potential treatment of multiple cancer indications.
Biospectrum Asia (http://www.biospectrumasia.com/content/260606OTH1000.asp)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct